Stock Screener App

Gratuito -

3.12

6.12% 0.18

Biocardia Inc (BCDA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Biocardia Inc Borsa (BCDA) Ultime notizie

Wall Street SWOT: BioCardia stock rides wave of FDA and CMS support for heart therapy - Investing.com

BioCardia, Inc. (NASDAQ:BCDA) Short Interest Update - Defense World

Trading Day Triumph: Biodesix Inc (BDSX) Ends at 1.59, a -11.67 Surge/Plunge - The Dwinnex

A new trading data show BriaCell Therapeutics Corp (BCTX) is showing positive returns. - SETE News

Dawson James downgrades BioCardia Inc. (BCDA) stock to a Neutral - Knox Daily

Harmony Asset Management LLC Trims Stock Position in The Boeing Company (NYSE:BA) - Defense World

The Boeing Company (NYSE:BA) Shares Sold by Edge Capital Group LLC - Defense World

Beck Capital Management LLC Has $1.47 Million Stock Position in The Boeing Company (NYSE:BA) - Defense World

Summit Trail Advisors LLC Boosts Stock Holdings in The Boeing Company (NYSE:BA) - Defense World

The time has not yet come to remove your chips from the table: Biolife Solutions Inc (BLFS) - SETE News

Sei Investments Co. Acquires 11,092 Shares of The Boeing Company (NYSE:BA) - Defense World

Market Watch Highlights: Biodexa Pharmaceuticals Plc ADR (BDRX) Ends on an Downturn Note at 0.29 - The Dwinnex

Avoro Capital Advisors LLC Has $77.68 Million Stock Holdings in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - Defense World

Discovery Capital Management LLC CT Invests $2.47 Million in BioNTech SE (NASDAQ:BNTX) - MarketBeat

Barrow Hanley Mewhinney & Strauss LLC Boosts Position in Bancolombia S.A. (NYSE:CIB) - MarketBeat

Benjamin F. Edwards & Company Inc. Buys 317 Shares of The Boeing Company (NYSE:BA) - Defense World

Benjamin Edwards Inc. Decreases Stake in Bank of America Co. (NYSE:BAC) - MarketBeat

Inspire Investing LLC Reduces Stock Position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - Defense World

Auxier Asset Management Decreases Stock Position in The Boeing Company (NYSE:BA) - Defense World

Comparing BioLargo (NASDAQ:BLGO) and Chemours (NYSE:CC) - Defense World

Sompo Asset Management Co. Ltd. Has $663,000 Stake in The Boeing Company (NYSE:BA) - Defense World

Benjamin Edwards Inc. Has $816,000 Position in The Boeing Company (NYSE:BA) - Defense World

BioLife Solutions (NASDAQ:BLFS) Trading Up 5.8% - Defense World

Bridges Investment Management Inc. Acquires New Position in Bank of America Co. (NYSE:BAC) - MarketBeat

Is Bank of America Corporation (BAC) the Best Affordable Stock To Buy Right Now? - Yahoo Finance

BANCO DO BRASIL/S (OTCMKTS:BDORY) Share Price Crosses Below 200-Day Moving Average of $5.38 - MarketBeat

Hollencrest Capital Management Boosts Holdings in The Boeing Company (NYSE:BA) - Defense World

Bank of America Corp. stock underperforms Friday when compared to competitors - MarketWatch

IPO News: Everything you need to know about BioAge Labs’ IPO - AlphaStreet

Builders FirstSource (NYSE:BLDR) Given New $198.00 Price Target at Bank of America - Defense World

DCF Advisers LLC Buys 250 Shares of The Boeing Company (NYSE:BA) - Defense World

Acadian Asset Management LLC Sells 107,112 Shares of BioNTech SE (NASDAQ:BNTX) - MarketBeat

BioCardia’s $7.2 Million Common Stock Offering - Global Legal Chronicle

Bank of America Corp. stock outperforms competitors on strong trading day - MarketWatch

The Boeing Company (NYSE:BA) Stock Holdings Lowered by Blair William & Co. IL - Defense World

The Boeing Company (NYSE:BA) Shares Bought by Garner Asset Management Corp - Defense World

BioCardia regains Nasdaq compliance, continues listing By Investing.com - Investing.com Canada

Sachin Tendulkar stock jumps 8% after it gets buy call for an upside of 20% - Trade Brains

FirstCry shares surge 7% after BofA, MS initiate coverage, see up to 27% upside scope - The Economic Times

Bank of America Declares Preferred Stock Dividends for Fourth Quarter 2024 - Quantisnow

BCDA’s Stochastic Averages Dip: Analyzing BioCardia Inc.’s Stock Performance - The InvestChronicle

BCDABioCardia, Inc. Latest Stock News & Market Updates - StockTitan

BioCardia regains Nasdaq compliance, continues listing By Investing.com - Investing.com Australia

BioCardia regains Nasdaq compliance, continues listing - Investing.com

BioCardia Regains Full Compliance with Nasdaq Listing Requirements - StockTitan

BLFS (Biolife Solutions Inc) may reap gains as insiders became active recently - Knox Daily

BioCardia Inc. [BCDA] Investment Appeal on the Rise - Knox Daily

BioCardia Announces Closing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules - ForexTV.com

BioCardia Announces Closing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules - StockTitan

Market Momentum: BioCardia Inc. (BCDA) Registers a -10.10 Decrease, Closing at 2.58 - The Dwinnex

Taking on analysts’ expectations and winning: BioCardia Inc. (BCDA) - SETE News

BioCardia Inc. [BCDA] Stock bought by Insider Altman Peter for $915.0 - Knox Daily

Wall Street Analyst Downgrade BioCardia Inc. [BCDA]. What else is Wall St. saying - The DBT News

Why BioCardia (BCDA) Stock Is Falling Today - MSN

BioCardia shares climb as it gets FDA clearance for its Morph DNA product family - MSN

BioCardia prices upsized public offering at $3 per share - Investing.com

BioCardia prices upsized public offering at $3 per share - Investing.com India

Dawson James slashes price target on BioCardia Inc. [BCDA] – find out why. - The DBT News

BioCardia Prices Public Offering - Baystreet.ca

BioCardia Shares Drop 10% After Public Offering Prices - MarketWatch

BioCardia Announces Pricing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules - StockTitan

Views of Wall Street’s Leading Experts on BioCardia Inc. - SETE News

BioCardia Inc (Nasdaq: BCDA) Achieves Significant FDA Clearance for Morph DNA Steerable Introducer, Paving New Pathways in Cardiovascular Interventions - BP Journal

BioCardia Inc.: -90.54% Growth from 52-Week Low, Yet Analysts Divided - The InvestChronicle

BioCardia Inc. [NASDAQ: BCDA] Sees Decrease in Stock Value - Knox Daily

BCDA’s price-to-sales ratio: Is it a good investment opportunity? - US Post News

Dow Jumps Over 100 Points; Nvidia Earnings Top Views - Benzinga

BioCardia (BCDA) Stock Sees Sharp Rise After An FDA Approval - Stocks Telegraph

Why BioCardia (BCDA) Stock Is Up 95% Today - Benzinga

BioCardia Announces FDA Market Clearance of Morph® DNA™ Steerable Introducer Product Family - StockTitan

Closing Figures: BioCardia Inc. (BCDA)’s Negative Finish at 2.20, Down -10.57 - The Dwinnex

BioCardia receives FDA clearance for new product - Investing.com

BioCardia Shares More Than Double After FDA Approves Medical Instrument Morph DNA Steerable Introducer - MarketWatch

BioCardia says FDA has cleared company to market its device, shares rise - XM

BioCardia, Inc. (NASDAQ:BCDA) Short Interest Up 104.1% in August - Defense World

$358.35

0.05%

$21.90

4.86%

$224.51

2.79%

$66.83

1.64%

$118.77

0.47%

$542.08

1.11%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Open in MarketWatch | Open in EDGAR | Open in Reuters